In-vitro Diagnostic Services Market Share Trends Growth Report 2024 

In-vitro Diagnostic Services Market Size By Service Type {Software (Standalone Software, Software Update), Testing Services (Infectious Testing, Diabetes Testing, Molecular Testing, Tissue Testing)}, By End-user (Hospitals, Point-Of-Care Testing, Laboratories, Academic Institutes), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 – 2024

Report Content

Chapter 1. Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. In-vitro diagnostic services industry 3600 synopsis, 2013 - 2024

2.1.1. Business trends

2.1.2. Service type trends

2.1.3. End-user trends

2.1.4. Regional trends

Chapter 3. In-vitro Diagnostic Services Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Growing cases of cancer in Asia Pacific and North America

3.3.1.2. Increasing detection rate of genetic and infectious diseases in Europe and U.S.

3.3.1.3. Rising number of liquid biopsy tests

3.3.1.4. Technological advancements in point of care testing services in Europe

3.3.2. Industry pitfalls and challenges

3.3.2.1. High cost of diagnosis service

3.4. Growth potential analysis

3.4.1. By service type

3.4.2. By end-user

3.5. Regulatory landscape

3.5.1. U.S.

3.5.2. Europe

3.6. Porter&rsquo;s analysis

3.7. Competitive landscape, 2017

3.7.1. Strategy dashboard

3.8. PESTEL analysis

Chapter 4. In-vitro Diagnostic Services Market, By Service Type

4.1. Key segment trends

4.2. Software

4.2.1. Market size, by region, 2013-2024 (USD Million)

4.2.2. Standalone software

4.2.2.1. Market size, by region, 2013-2024 (USD Million)

4.2.3. Software update

4.2.3.1. Market size, by region, 2013-2024 (USD Million)

4.2.4. Others

4.2.4.1. Market size, by region, 2013-2024 (USD Million)

4.3. Testing services

4.3.1. Market size, by region, 2013-2024 (USD Million)

4.3.2. Infectious testing

4.3.2.1. Market size, by region, 2013-2024 (USD Million)

4.3.3. Diabetes testing

4.3.3.1. Market size, by region, 2013-2024 (USD Million)

4.3.4. Molecular testing

4.3.4.1. Market size, by region, 2013-2024 (USD Million)

4.3.5. Tissue testing

4.3.5.1. Market size, by region, 2013-2024 (USD Million)

4.3.6. Others

4.3.6.1. Market size, by region, 2013-2024 (USD Million)

Chapter 5. In-vitro Diagnostic Services Market, By End-user

5.1. Key segment trend

5.2. Hospitals

5.2.1. Market size, by region, 2013-2024 (USD Million)

5.3. Point-of-care testing

5.3.1. Market size, by region, 2013-2024 (USD Million)

5.4. Laboratories

5.4.1. Market size, by region, 2013-2024 (USD Million)

5.5. Academic institutes

5.5.1. Market size, by region, 2013-2024 (USD Million)

5.6. Others

5.6.1. Market size, by region, 2013-2024 (USD Million)

Chapter 6. In-vitro Diagnostic Services Market, By Region

6.1. Key regional market

6.2. North America

6.2.1. Market size, by country, 2013 - 2024(USD Million)

6.2.2. Market size, by service type, 2013 - 2024(USD Million)

6.2.2.1. Market size, by software, 2013 - 2024(USD Million)

6.2.2.2. Market size, by testing services, 2013 - 2024(USD Million)

6.2.3. Market size, by end-user, 2013 - 2024(USD Million)

6.2.4. U.S.

6.2.4.1. Market size, by service type, 2013 - 2024(USD Million)

6.2.4.1.1. Market size, by software, 2013 - 2024(USD Million)

6.2.4.1.2. Market size, by testing services, 2013 - 2024(USD Million)

6.2.4.2. Market size, by end-user, 2013 - 2024(USD Million)

6.2.5. Canada

6.2.5.1. Market size, by service type, 2013 - 2024(USD Million)

6.2.5.1.1. Market size, by software, 2013 - 2024(USD Million)

6.2.5.1.2. Market size, by testing services, 2013 - 2024(USD Million)

6.2.5.2. Market size, by end-user, 2013 - 2024(USD Million)

6.3. Europe

6.3.1. Market size, by country, 2013 - 2024(USD Million)

6.3.2. Market size, by service type, 2013 - 2024(USD Million)

6.3.2.1. Market size, by software, 2013 - 2024(USD Million)

6.3.2.2. Market size, by testing services, 2013 - 2024(USD Million)

6.3.3. Market size, by end-user, 2013 - 2024(USD Million)

6.3.4. Germany

6.3.4.1. Market size, by service type, 2013 - 2024(USD Million)

6.3.4.1.1. Market size, by software, 2013 - 2024(USD Million)

6.3.4.1.2. Market size, by testing services, 2013 - 2024(USD Million)

6.3.4.2. Market size, by end-user, 2013 - 2024(USD Million)

6.3.5. France

6.3.5.1. Market size, by service type, 2013 - 2024(USD Million)

6.3.5.1.1. Market size, by software, 2013 - 2024(USD Million)

6.3.5.1.2. Market size, by testing services, 2013 - 2024(USD Million)

6.3.5.2. Market size, by end-user, 2013 - 2024(USD Million)

6.3.6. UK

6.3.6.1. Market size, by service type, 2013 - 2024(USD Million)

6.3.6.1.1. Market size, by software, 2013 - 2024(USD Million)

6.3.6.1.2. Market size, by testing services, 2013 - 2024(USD Million)

6.3.6.2. Market size, by end-user, 2013 - 2024(USD Million)

6.3.7. Italy

6.3.7.1. Market size, by service type, 2013 - 2024(USD Million)

6.3.7.1.1. Market size, by software, 2013 - 2024(USD Million)

6.3.7.1.2. Market size, by testing services, 2013 - 2024(USD Million)

6.3.7.2. Market size, by end-user, 2013 - 2024(USD Million)

6.3.8. Spain

6.3.8.1. Market size, by service type, 2013 - 2024(USD Million)

6.3.8.1.1. Market size, by software, 2013 - 2024(USD Million)

6.3.8.1.2. Market size, by testing services, 2013 - 2024(USD Million)

6.3.8.2. Market size, by end-user, 2013 - 2024(USD Million)

6.3.9. Russia

6.3.9.1. Market size, by service type, 2013 - 2024(USD Million)

6.3.9.1.1. Market size, by software, 2013 - 2024(USD Million)

6.3.9.1.2. Market size, by testing services, 2013 - 2024(USD Million)

6.3.9.2. Market size, by end-user, 2013 - 2024(USD Million)

6.4. Asia Pacific

6.4.1. Market size, by country, 2013 - 2024(USD Million)

6.4.2. Market size, by service type, 2013 - 2024(USD Million)

6.4.2.1. Market size, by software, 2013 - 2024(USD Million)

6.4.2.2. Market size, by testing services, 2013 - 2024(USD Million)

6.4.3. Market size, by end-user, 2013 - 2024(USD Million)

6.4.4. China

6.4.4.1. Market size, by service type, 2013 - 2024(USD Million)

6.4.4.1.1. Market size, by software, 2013 - 2024(USD Million)

6.4.4.1.2. Market size, by testing services, 2013 - 2024(USD Million)

6.4.4.2. Market size, by end-user, 2013 - 2024(USD Million)

6.4.5. Japan

6.4.5.1. Market size, by service type, 2013 - 2024(USD Million)

6.4.5.1.1. Market size, by software, 2013 - 2024(USD Million)

6.4.5.1.2. Market size, by testing services, 2013 - 2024(USD Million)

6.4.5.2. Market size, by end-user, 2013 - 2024(USD Million)

6.4.6. India

6.4.6.1. Market size, by service type, 2013 - 2024(USD Million)

6.4.6.1.1. Market size, by software, 2013 - 2024(USD Million)

6.4.6.1.2. Market size, by testing services, 2013 - 2024(USD Million)

6.4.6.2. Market size, by end-user, 2013 - 2024(USD Million)

6.4.7. Australia

6.4.7.1. Market size, by service type, 2013 - 2024(USD Million)

6.4.7.1.1. Market size, by software, 2013 - 2024(USD Million)

6.4.7.1.2. Market size, by testing services, 2013 - 2024(USD Million)

6.4.7.2. Market size, by end-user, 2013 - 2024(USD Million)

6.5. Latin America

6.5.1. Market size, by country, 2013 - 2024(USD Million)

6.5.2. Market size, by service type, 2013 - 2024(USD Million)

6.5.2.1. Market size, by software, 2013 - 2024(USD Million)

6.5.2.2. Market size, by testing services, 2013 - 2024(USD Million)

6.5.3. Market size, by end-user, 2013 - 2024(USD Million)

6.5.4. Brazil

6.5.4.1. Market size, by service type, 2013 - 2024(USD Million)

6.5.4.1.1. Market size, by software, 2013 - 2024(USD Million)

6.5.4.1.2. Market size, by testing services, 2013 - 2024(USD Million)

6.5.4.2. Market size, by end-user, 2013 - 2024(USD Million)

6.5.5. Mexico

6.5.5.1. Market size, by service type, 2013 - 2024(USD Million)

6.5.5.1.1. Market size, by software, 2013 - 2024(USD Million)

6.5.5.1.2. Market size, by testing services, 2013 - 2024(USD Million)

6.5.5.2. Market size, by end-user, 2013 - 2024(USD Million)

6.6. MEA

6.6.1. Market size, by country, 2013 - 2024(USD Million)

6.6.2. Market size, by service type, 2013 - 2024(USD Million)

6.6.2.1. Market size, by software, 2013 - 2024(USD Million)

6.6.2.2. Market size, by testing services, 2013 - 2024(USD Million)

6.6.3. Market size, by end-user, 2013 - 2024(USD Million)

6.6.4. Saudi Arabia

6.6.4.1. Market size, by service type, 2013 - 2024(USD Million)

6.6.4.1.1. Market size, by software, 2013 - 2024(USD Million)

6.6.4.1.2. Market size, by testing services, 2013 - 2024(USD Million)

6.6.4.2. Market size, by end-user, 2013 - 2024(USD Million)

6.6.5. South Africa

6.6.5.1. Market size, by service type, 2013 - 2024(USD Million)

6.6.5.1.1. Market size, by software, 2013 - 2024(USD Million)

6.6.5.1.2. Market size, by testing services, 2013 - 2024(USD Million)

6.6.5.2. Market size, by end-user, 2013 - 2024(USD Million)

6.6.6. UAE

6.6.6.1. Market size, by service type, 2013 - 2024(USD Million)

6.6.6.1.1. Market size, by software, 2013 - 2024(USD Million)

6.6.6.1.2. Market size, by testing services, 2013 - 2024(USD Million)

6.6.6.2. Market size, by end-user, 2013 - 2024(USD Million)

Chapter 7. Company Profiles

7.1. bioMerieux

7.1.1. Business overview

7.1.2. Financial data

7.1.3. Product landscape

7.1.4. Strategic outlook

7.1.5. SWOT analysis

7.2. Bio-Rad Laboratories

7.2.1. Business overview

7.2.2. Financial data

7.2.3. Product landscape

7.2.4. Strategic outlook

7.2.5. SWOT analysis

7.3. DexCom, Inc

7.3.1. Business overview

7.3.2. Financial data

7.3.3. Product landscape

7.3.4. Strategic outlook

7.3.5. SWOT analysis

7.4. Nova Biomedical

7.4.1. Business overview

7.4.2. Financial data

7.4.3. Product landscape

7.4.4. Strategic outlook

7.4.5. SWOT analysis

7.5. OraSure Technologies

7.5.1. Business overview

7.5.2. Financial data

7.5.3. Product landscape

7.5.4. Strategic outlook

7.5.5. SWOT analysis

7.6. Ortho Clinical Diagnostics

7.6.1. Business overview

7.6.2. Financial data

7.6.3. Product landscape

7.6.4. Strategic outlook

7.6.5. SWOT analysis

7.7. Qiagen

7.7.1. Business overview

7.7.2. Financial data

7.7.3. Product landscape

7.7.4. Strategic outlook

7.7.5. SWOT analysis

7.8. Roche Diagnostics

7.8.1. Business overview

7.8.2. Financial data

7.8.3. Product landscape

7.8.4. Strategic outlook

7.8.5. SWOT analysis

7.9. Siemens AG

7.9.1. Business overview

7.9.2. Financial data

7.9.3. Product landscape

7.9.4. Strategic outlook

7.9.5. SWOT analysis

7.10. Sysmex Corporation

7.10.1. Business overview

7.10.2. Financial data

7.10.3. Product landscape

7.10.4. Strategic outlook

7.10.5. SWOT analysis

7.11. Thermo Fisher Scientific

7.11.1. Business overview

7.11.2. Financial data

7.11.3. Product landscape

7.11.4. Strategic outlook

7.11.5. SWOT analysis

&nbsp;

In-vitro Diagnostic Services Market

Inquiry Before Buying

Industries

Information

Link

Global Headquarters